2024 Europe Cell Surface Markers: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Country, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers
The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
More Publications
Cell Surface Markers: France, Germany, Italy, Spain, UK-Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 3,080.00
June 2016
125 pages
Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares, Sales Forecasts by Test and Market Segment, Competitive Strategies, Technology Trends, Instrumentation Review
US$ 14,500.00
July 2019
630 pages
Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Supplier Shares, Sales Forecasts by Test, Competitive Strategies, Technology Trends, Instrumentation Review
US$ 15,760.00
July 2016
630 pages
